127 related articles for article (PubMed ID: 2449013)
1. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
Chang A; van de Kerkhof PC
Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
[TBL] [Abstract][Full Text] [Related]
2. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
Eriksen K
Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene B4-induced accumulation of polymorphonuclear leukocytes in psoriatic skin.
van de Kerkhof PC; Lammers AM; Mier PD; Happle R
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():637-9. PubMed ID: 2823562
[No Abstract] [Full Text] [Related]
5. Atrophic skin striae following the use of clobetasol propionate ointment.
Hardie RA; Waring AJ; Barnetson RS
Practitioner; 1977 Sep; 219(1311):376-8. PubMed ID: 928283
[No Abstract] [Full Text] [Related]
6. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report.
Lane PR; Moreland AA; Hogan DJ
Arch Dermatol; 1990 Sep; 126(9):1211-3. PubMed ID: 2396838
[TBL] [Abstract][Full Text] [Related]
7. PUVA and UVB inhibit the intra-epidermal accumulation of polymorphonuclear leukocytes.
Chang A; Alkemade JA; van de Kerkhof PC
Br J Dermatol; 1988 Sep; 119(3):281-7. PubMed ID: 2846029
[TBL] [Abstract][Full Text] [Related]
8. The use and abuse of 0.05 per cent clobetasol propionate in dermatology.
Harris DW; Hunter JA
Dermatol Clin; 1988 Oct; 6(4):643-7. PubMed ID: 3229014
[TBL] [Abstract][Full Text] [Related]
9. Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.
Ahn SK; Bak HN; Park BD; Kim YH; Youm JK; Choi EH; Hong SP; Lee SH
J Dermatol; 2006 Feb; 33(2):80-90. PubMed ID: 16556273
[TBL] [Abstract][Full Text] [Related]
10. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Serup J; Holm P
Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
[TBL] [Abstract][Full Text] [Related]
11. A clinical trial of clobetasol propionate in Filipino vitiligo patients.
Geraldez CB; Gutierrez GT
Clin Ther; 1987; 9(5):474-82. PubMed ID: 3311364
[TBL] [Abstract][Full Text] [Related]
12. Contact allergy to clobetasol propionate.
Cox NH
Arch Dermatol; 1988 Jun; 124(6):911-3. PubMed ID: 2967675
[TBL] [Abstract][Full Text] [Related]
13. Effects of topically applied clobetasol-17-propionate on histamine release in human skin.
Ståhle M; Hägermark O
Acta Derm Venereol; 1984; 64(3):239-42. PubMed ID: 6204486
[TBL] [Abstract][Full Text] [Related]
14. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
Ong JT; Poulsen BJ; Akers WA; Scholtz JR; Genter FC; Kertesz DJ
Arch Dermatol; 1989 Dec; 125(12):1662-5. PubMed ID: 2589861
[TBL] [Abstract][Full Text] [Related]
16. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
Beutner K; Chakrabarty A; Lemke S; Yu K
J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
[TBL] [Abstract][Full Text] [Related]
17. Clobetasol--a potent new topical corticosteroid.
Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
[No Abstract] [Full Text] [Related]
18. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison between a new trihalogenated dermatocorticosteroid (halometasone) cream and clobetasol 17-propionate (Dermovate) cream.
Schwarz KJ; Konzelmann M; Yawalkar SJ; Schoenenberger PM
Br J Clin Pract; 1982 May; 36(5):192-6. PubMed ID: 6756453
[No Abstract] [Full Text] [Related]
20. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
